Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland

Objective: To compare projected economic costs and health benefits associated with using pneumococcal conjugate heptavalent vaccine as routine immunisation in healthy children in Switzerland. Design: A cost-utility analysis was performed from both the societal as well as the sickness funds’ perspect...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 2003-07, Vol.21 (23), p.3273-3281
Hauptverfasser:	Ess, Silvia M, Schaad, Urs B, Gervaix, Alain, Pinösch, Seline, Szucs, Thomas D
Format:	Artikel
Sprache:	eng
Schlagworte:	Bacteremia - economics Bacteremia - epidemiology Bacteremia - prevention & control Biological and medical sciences Child, Preschool Children & youth Cost effectiveness Cost of Illness Cost-Benefit Analysis Cost-utility analysis Decision Support Techniques Fatalities Funds Humans Immunization Immunization Programs - economics Infant Infant, Newborn Infants Medical sciences Meningitis Meningitis, Pneumococcal - economics Meningitis, Pneumococcal - epidemiology Meningitis, Pneumococcal - prevention & control Otitis media Pneumococcal conjugate immunisation Pneumococcal Infections - economics Pneumococcal Infections - epidemiology Pneumococcal Infections - prevention & control Pneumococcal meningitis Pneumococcal Vaccines - economics Pneumonia Pneumonia, Pneumococcal - economics Pneumonia, Pneumococcal - epidemiology Pneumonia, Pneumococcal - prevention & control Prevention and actions Public health. Hygiene Public health. Hygiene-occupational medicine Specific populations (family, woman, child, elderly...) Streptococcus pneumoniae Switzerland - epidemiology Treatment Outcome Vaccines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!